Brind.

Research Findings on PALI-2108 Presented at UEG Week 2026 Conference

1 report, 1 independent Updated Sep 28
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Florian Rieder presented research findings at the United European Gastroenterology (UEG) Week 2026 conference. The presentations focused on the lead program, PALI-2108, a candidate for inflammatory bowel disease. The findings included an oral presentation of Phase 1b results in fibrostenotic Crohn’s disease, alongside three moderated posters detailing data on ulcerative colitis and a potential predictive biomarker.

From manilatimes.net

Why it matters

Some supportBrind's analysis of the reports

The presentations provide clinical and translational support for the continued development of PALI-2108 as a once-daily oral treatment. The data addresses early clinical activity, favorable safety and tolerability, and gut-targeted exposure.

From manilatimes.net

Who's involved

  • United European GastroenterologyNon-profit organization hosting the conference on digestive health.
  • Florian RiederResearcher who presented the findings regarding PALI-2108.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped